 

 

 

L

FINAL DIAGNOSIS:

PART 1: BREAST LEFT, 12 O’ CLOCK NEEDLE LOCALIZED EXCISIONAL BIOPSY -

PART3: BREAST RIGHT, NEW MARGIN, EXCISION—

ATYPICAL DUCTAL EPITHELIAL HYPERPLASIA (see comment).

COMPLEX PAPILLARY PROLIFERATIVE LESIONS.

DUCTAL EPITHELIAL HYPERPLASIA.

ADENOSIS AND SCLEROSING ADENOSIS.

COLUMNAR CELL CHANGES AND HYPERPLASIA WITH ASSOCIATED MICROCALCIFICATIONS.
FIBROCYSTIC CHANGES WITH APOCRINE METAPLASIA.

DUCT ECTASIA.

MICROSCOPIC RADIAL SCARS.

MARKED CAUTERY ARTIFACT.

BIOPSY RELATED CHANGES.

F’FPWWPP?>

PART 23 WUCLOCK, NEEDLE LOCALIZED SEGMENTAL MASTECTOMY —

A. INVASIVE DUCTAL CARCINOMA WITH LOBULAR FEATURES, 3. 2 CM (GROSS), NOTTINGHAM GRADE 2/3
(cOMBINE‘EN‘OTTIN’EﬁANI'SCURE 6/9: TUBULE FORMATION 3/3, NUCLEAR ATYPIA 2/3, MITOTIC ACTIVITY
1I3) (see comment).

DEFINITIVE DUCTAL CARCINOMA IN SITU IS NOT IDENTIFIED.

EXTENSIVE LYMPHOVASCULAR INVASION.

MARGINS FREE, CLOSEST MEDIAL. ANTERIOR. DEEP AND INFERIOR WITHIN 0.5 CM.

ATYPICAL DUCTAL EPITHELIAL HYPERPLASIA.
FIBROCYSTIC CHANGES.

INTRADUCTAL PAPILLOMA.

BIOPSY SITE CHANGES.

MARKED CAUTERY ARTIFACT.

PATHOLOGIC: STAGE (see comment).

FP;QFFPQP

UUID: 9714A9FB- 8567- 43E6- 9D56- 1852F501F67e5d
TCGA— BH- ABBC- OlA- PR

HI llIIIIHIHIIIIlIIlIIlllIIIIIIIIIIIIIIllNl
llllllmflllli”IIIIIHIIIIIIIIIIIlll ||I| |||||I||||| l|| ||||l|||||||
IIIIlllllIIIIIHIIIIIIIIIIIIIIHlllllllllllllllllllllllllllll

COMPLEX PAPILLARY PROLIFERATIVE LESION. Ill
DUCTAL EPITHELIAL HYPERPLASIA. Hll

 

ADENOSIS AND SCLEROSING ADENOSIS.

COLUMNAR CELL CHANGES AND HYPERPLASIA.
FIBROCYSTIC CHANGES WITH APOCRINE METAPLASIA.
DUCT ECTASIA. _

MARKED CAUTERY ARTIFACT.

PTWPPF’?"

”——

ART 4: SENTINEL LYMPH NODE # 1, RIGHT, BIOPSY -

A. METASTATIC CARCINOMA INVOLVING ONE LYMPH NODE.
B. METASTATIC FOCUS, 1.2 CM IN GREATEST DIAMETER (ENTIRE LYMPH NODE).

 

C. EXTRACAPSULAR EXTENSION IS IDENTIFIED, 0.5 CM X 0. 2 CM.

 

         
 

 

 

:—
CASE SYNOPSIS:
SYNOPTIC - PRIMARY INVASIVE CARCINOMA OF BREAST
LATERALITY: Right
PROCEDURE: Segmental
LOCATION: Not speciﬁed
SIZE OF TUMOR: Maximum dimension invasive component: 3.2 cm
MULTICENTRICITYIMULTIFOCALITY OF INVASIVE FOCI:
NO / (/0 ' d / 5
TUMOR TYPE (invasive component): - (I - ~ W M/ m 3556/3
Ductai adenocarcmoma, NOS _ I 7
NOTTINGHAM SCORE: 1Nu§Ielarfgradef 2 3 am : W AM: 6:70. 9 3/13/11
u u e orma Ion:
Mitotic activity score: 1
Total Nottingham score: 6
Nottingham grade (1 . 2. 3): 2
ANGIOLYMPHATIC INVASION: Yes
DERMAL LYMPHATIC INVASION: Not applicable
CALCIFICATION: Yes, benign zones mam
SURGICAL MARGINS INVOLVED BY INVASIVE COMPONENT: W
N 0 ”PM DMZ; It: Diane-my
SURG MARGINS INVOLVED BY IN SITU COMPONENT: M
NO me I: (.1m;:7°“"”""rv~ a
LYMPH NODES POSITIVE: 1 41"“?
LYMPH MODES EXAMINED: 1
METHOD(S) OF LYMPH NODE EXAMINATION:
HIE stain
SIZE OF NODAL METASTASES: Diameter of largest lymph node metastasis: 15.0 mm
LYMPH NODE METASTASISI-ES) WITH EXTRACAPSULAR EXTENSION:
Yes
NON-NEOPLASTIC BREAST TISSUE: ADH
T STAGE. PATHOLOGIC: pT2
N STAGE, PATHOLOGIC: pN1
______M_$_TA(E, PATHOLOGIC: pMX
ESTROGEN RECEPTORS: positive

PROGESTERONE RECEPTORS: positive
HERZINEU: zero or 1+

 

